OPTN stock forecast
Our latest prediction for OptiNose, Inc.'s stock price was made on the Nov. 25, 2019 when the stock price was at 9.73$.
In the short term (2weeks), OPTN's stock price should underperform the market by -5.51%. During that period the price should oscillate between -13.03% and +9.20%.
In the medium term (3months), OPTN's stock price should underperform the market by -14.26%. During that period the price should oscillate between -35.95% and +20.76%.Get email alerts
About OptiNose, Inc.
OptiNose, Inc. is a pharmaceutical company, which engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
At the moment the company generates 27M USD in revenues.
On its last earning announcement, the company reported a loss of -2.70$ per share.
The book value per share is 3.99$
Three months stock forecastNov. 25, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|